NetworkNewsBreaks – SinglePoint, Inc. (SING) Eye
Post# of 1137
(Total Views: 345)
Posted On: 01/10/2019 6:09:15 PM
NetworkNewsBreaks – SinglePoint, Inc. (SING) Eyes Opportunity in 2019, Highlights Company Initiatives and Acquisitions
Technology and investment company SinglePoint (OTCQB: SING) this morning provided insight into the company’s direction, intended acquisition plans and previous successful acquisitions it has completed to date. According to the update, the company has achieved major success in its industrial hemp CBD related initiatives, with its subsidiary SingleSeed.com receiving a steady increased volume of orders expected to be a key factor in driving increased revenue in 2019. The company is optimizing its site with different landing pages and utilizing tools such a heat maps and A/B testing to target enhanced visitor experience and increased conversion of site visits. SingleSeed continues to launch new products with intentions to add CBD for pets in the near future. In addition to success of its SingleSeed subsidiary, SING has invested in TorusMed, a company working to develop CBD using photobioreactors, with the ultimate goal of cultivating pharmaceutical grade CBD in lab settings to ensure consistency.
Additionally, SING continues to review potential new acquisitions and investments, while completing active discussions regarding potential opportunities to drive revenue and solidify its position in the industrial hemp CBD market. These opportunities include industrial hemp production, product manufacturing, distribution, and targeted sales expansions to convenience stores, vape shops, liquor stores, and more. In addition to its strategic plans and potential growth in the CBD market, the company continues to build upon existing initiatives and expand growth and opportunities through previous successful acquisitions, such as ShieldSaver and DIGS.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Technology and investment company SinglePoint (OTCQB: SING) this morning provided insight into the company’s direction, intended acquisition plans and previous successful acquisitions it has completed to date. According to the update, the company has achieved major success in its industrial hemp CBD related initiatives, with its subsidiary SingleSeed.com receiving a steady increased volume of orders expected to be a key factor in driving increased revenue in 2019. The company is optimizing its site with different landing pages and utilizing tools such a heat maps and A/B testing to target enhanced visitor experience and increased conversion of site visits. SingleSeed continues to launch new products with intentions to add CBD for pets in the near future. In addition to success of its SingleSeed subsidiary, SING has invested in TorusMed, a company working to develop CBD using photobioreactors, with the ultimate goal of cultivating pharmaceutical grade CBD in lab settings to ensure consistency.
Additionally, SING continues to review potential new acquisitions and investments, while completing active discussions regarding potential opportunities to drive revenue and solidify its position in the industrial hemp CBD market. These opportunities include industrial hemp production, product manufacturing, distribution, and targeted sales expansions to convenience stores, vape shops, liquor stores, and more. In addition to its strategic plans and potential growth in the CBD market, the company continues to build upon existing initiatives and expand growth and opportunities through previous successful acquisitions, such as ShieldSaver and DIGS.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)